Ana Camarozano

Prof. Ana Camarozano

Feeders university Parana

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EPEugenio Picano
Eugenio Picano
QCQuirino Ciampi
Quirino Ciampi
LCLauro Cortigiani
Lauro Cortigiani
AAAdelaide M. Arruda-Olson
Adelaide M. Arruda-Olson
Clarissa Borguezan DarosClarissa Borguezan Daros
Clarissa Borguezan Daros
T(The Stress Echo 2030 Study Group of the Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI)
The Stress Echo 2030 Study Group of the Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI)
With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021–2025) ≥10,000 patients followed for ≥5 years (up to 2030) from ≥20 quality-controlled laboratories from ≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.

1 September 2023 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
AAAndré De Almeida
André De Almeida
MMmarcelo dantas tavares de melo
marcelo dantas tavares de melo
DBDavid Costa de Souza Le Bihan
David Costa de Souza Le Bihan
MVMarcelo Luiz Vieira
Marcelo Luiz Vieira
JPJosé Luiz Barros Pena
José Luiz Barros Pena
AFAlex Felix
Alex Felix
Sumário 1. Conceitos Básicos sobre o Estudo da Deformação do Ventrículo Esquerdo 7 1.1. Breve Introdução aos Princípios Físicos da Formação dos Speckles na Imagem Cardiovascular 7 […] Posicionamento do Departamento de Imagem Cardiovascular da Sociedade Brasileira de Cardiologia sobre o Uso do Strain Miocárdico na Rotina do Cardiologista – 2023 Sumário 1. Conceitos Básicos sobre o Estudo da Deformação do Ventrículo Esquerdo 7 1.1. Breve Introdução aos Princípios Físicos da Formação dos Speckles na Imagem Cardiovascular 7 […] Posicionamento do Departamento de Imagem Cardiovascular da Sociedade Brasileira de Cardiologia sobre o Uso do Strain Miocárdico na Rotina do Cardiologista – 2023

15 October 2020 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
DMDoralisa Morrone
Doralisa Morrone
RARosina Arbucci
Rosina Arbucci
KWKarina Wierzbowska-Drabik
Karina Wierzbowska-Drabik
QCQuirino Ciampi
Quirino Ciampi
JPJesus Peteiro
Jesus Peteiro
EPEugenio Picano
Eugenio Picano

26 May 2021 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
CCCléa Simone Sabino de Souza Colombo
Cléa Simone Sabino de Souza Colombo
MLMarcelo Bichels Leitão
Marcelo Bichels Leitão
AAAntônio Carlos Avanza
Antônio Carlos Avanza
SBSerafim Ferreira Borges
Serafim Ferreira Borges
ASAnderson Donelli da Silveira
Anderson Donelli da Silveira
NGNabil Ghorayeb
Nabil Ghorayeb
1. Introdução Em 30 de janeiro de 2020, a Organização Mundial da Saúde (OMS) declarou que o surto da doença (COVID-19) causada pelo novo coronavírus (SARS-CoV-2) representava uma “Emergência de Saúde Pública de Importância Internacional” – o mais alto nível de alerta da organização, conforme previsto no Regulamento Sanitário Internacional. Comparado com o SARS-CoV que causou um surto de síndrome respiratória aguda grave (SARS) em 2003, o SARS-CoV-2 tem capacidade de transmissão mais alta. O rápido aumento de casos confirmados [...] 1. Introdução Em 30 de janeiro de 2020, a Organização Mundial da Saúde (OMS) declarou que o surto da doença (COVID-19) causada pelo novo coronavírus (SARS-CoV-2) representava uma “Emergência de Saúde Pública de Importância Internacional” – o mais alto nível de alerta da organização, conforme previsto no Regulamento Sanitário Internacional. Comparado com o SARS-CoV que causou um surto de síndrome respiratória aguda grave (SARS) em 2003, o SARS-CoV-2 tem capacidade de transmissão mais alta. O rápido aumento de casos confirmados

1 August 2022 in Global Heart
Verified
Journal Article
Open access
PDF file
SSSalvador V. Spina
Salvador V. Spina
MVMarcelo Luiz Vieira
Marcelo Luiz Vieira
CHCésar Jose Herrera
César Jose Herrera
AEAna G. Munera Echeverri
Ana G. Munera Echeverri
PRPamela Rojo
Pamela Rojo
RPRicardo Pignatelli
Ricardo Pignatelli
Describe the use and findings of cardiopulmonary imaging—chest X-ray (cX-ray), echocardiography (cEcho), chest CT (cCT), lung ultrasound (LUS), and/or cardiac magnetic resonance imaging (cMRI)—in COVID-19 hospitalizations in Latin America (LATAM). There is a lack of information on the images used and their findings during the SARS-CoV-2 pandemic in LATAM. Multicenter, prospective, observational study of COVID-19 inpatients, conducted from March to December 2020, from 12 high-complexity centers, in nine LATAM countries. Adults (>18 years) with at least one imaging modality performed, followed from admission until discharge and/or in-hospital death, were included. We studied 1,435 hospitalized patients (64% males) with a median age of 58 years classified into three regions: Mexico (Mx), 262; Central America and Caribbean (CAC), 428; and South America (SAm), 745. More frequent comorbidities were overweight/obesity, hypertension, and diabetes. During hospitalization, 58% were admitted to the ICU. The in-hospital mortality was 28%, and it was highest in Mx (37%). The most frequent images performed were cCT (61%), mostly in Mx and SAm, and cX-ray (46%), significant in CAC. The cEcho was carried out in 18%, similarly among regions, and LUS was carried out in 7%, with a higher frequently in Mx. Abnormal findings on the cX-ray were peripheral or basal infiltrates, and in cCT abnormal findings were the ground glass infiltrates, more commonly in Mx. In LUS, interstitial syndrome was the most abnormal finding, predominantly in Mx and CAC. Renal failure was the most prevalent complication (20%), predominant in Mx and SAm. Heart failure developed in 13%, predominant in Mx and CAC. Lung thromboembolism was higher in Mx while myocardial infarction was in CAC. Logistic regression showed associations of abnormal imaging findings and their severity, with comorbidities, complications, and evolution. The use and findings of cardiopulmonary imaging in LATAM varied between regions and had a great impact on diagnosis and prognosis.

1 January 2019 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
LBLiz Andréa Villela Baroncini
Liz Andréa Villela Baroncini
LBLucas José Lira Borges
Lucas José Lira Borges
ACAna Camarozano
Ana Camarozano
DCDaniela de Castro Carmo
Daniela de Castro Carmo
RDRubens Zenobio Darwich
Rubens Zenobio Darwich
JJJeronimo Antonio Fortunato Junior
Jeronimo Antonio Fortunato Junior
Few reports exist on the relationship of the left ventricular diastolic dysfunction (LVDD) with its most important features including enlargement of the left atrium and left ventricular hypertrophy (LVH), and with the right ventricular (RV) function. To determine the correlation between the left atrial size and the RV function and dimensions in patients with and without LVDD and LVH. Fifty patients were included, 25 (40% men) of them with LVDD, aged 67.1 ± 10.6 years (study group) and 25 without LVDD (52% men) aged 49.9 ± 16.3 years (control group). Patients underwent transthoracic echocardiography with evaluation of the left atrial size and volume (LAV), LVDD, LVH, and RV function and dimensions. P-values < 0.05 were considered statistically significant. LAV > 34 mL/m2 and left atrial size > 40 mm were associated with lower absolute values of tricuspid annular plane systolic excursion (TAPSE) and RV lateral S' (p ≤ 0.001, Pearson's correlation coefficient -0.4 and -0.38, respectively) in the study group. Patients in the study group showed higher incidence of LVH (p = 0.02) and greater left atrial diameter (p = 0.03) compared with the control group. In addition, greater left atrial diameter (p = 0.02) and LAV (p = 0.01) values were found in patients with LVDD grade II compared with LVDD grade I. The present study determined, for the first time, the correlation of left atrial enlargement with progressive RV dysfunction in patients with LVDD.